pRC-CMV-Rev1b Citations (7)
Originally described in: COVID-19-neutralizing antibodies predict disease severity and survival.Garcia-Beltran WF, Lam EC, Astudillo MG, Yang D, Miller TE, Feldman J, Hauser BM, Caradonna TM, Clayton KL, Nitido AD, Murali MR, Alter G, Charles RC, Dighe A, Branda JA, Lennerz JK, Lingwood D, Schmidt AG, Iafrate AJ, Balazs AB Cell. 2021 Jan 21;184(2):476-488.e11. doi: 10.1016/j.cell.2020.12.015. Epub 2020 Dec 15. PubMed Journal
Articles Citing pRC-CMV-Rev1b
Articles |
---|
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant.
Garcia-Beltran WF, St Denis KJ, Hoelzemer A, Lam EC, Nitido AD, Sheehan ML, Berrios C, Ofoman O, Chang CC, Hauser BM, Feldman J, Roederer AL, Gregory DJ, Poznansky MC, Schmidt AG, Iafrate AJ, Naranbhai V, Balazs AB.
Cell. 2022 Jan 6. pii: S0092-8674(21)01496-3. doi: 10.1016/j.cell.2021.12.033.
PubMed
Associated Plasmids |
Inhibition of mTOR signaling protects human glioma cells from hypoxia-induced cell death in an autophagy-independent manner. Dive I, Klann K, Michaelis JB, Heinzen D, Steinbach JP, Munch C, Ronellenfitsch MW. Cell Death Discov. 2022 Oct 6;8(1):409. doi: 10.1038/s41420-022-01195-y. PubMed |
Changes within the P681 residue of spike dictate cell fusion and syncytia formation of Delta and Omicron variants of SARS-CoV-2 with no effects on neutralization or infectivity. Kuzmina A, Korovin D, Cohen Lass I, Atari N, Ottolenghi A, Hu P, Mandelboim M, Rosental B, Rosenberg E, Diaz-Griffero F, Taube R. Heliyon. 2023 Jun;9(6):e16750. doi: 10.1016/j.heliyon.2023.e16750. Epub 2023 Jun 3. PubMed |
Imaging and quantitative analysis of integrin-dependent cell-matrix adhesions. van Stalborch AD, Clark AG, Sonnenberg A, Margadant C. STAR Protoc. 2023 Sep 15;4(3):102473. doi: 10.1016/j.xpro.2023.102473. Epub 2023 Aug 23. PubMed |
Viral and immunologic evaluation of smokers with severe COVID-19. Vecchio J, Regan J, Jiang Y, Li R, Romain H, Yousuf F, Adel T, Hall K, DaCosta JM, Yu X, Li JZ, Fofana IB. Sci Rep. 2023 Oct 19;13(1):17898. doi: 10.1038/s41598-023-45195-z. PubMed |
Safety and immunogenicity of CoronaVac and ChAdOx1 heterologous prime-boost vaccines in an overweight population in Chiang Mai, Thailand. Chawansuntati K, Sakkhachornphop S, Hongjaisee S, Freeouf S, Sripan P, Nusartsang N, Chaiwarith R, Sudjaritruk T, Supparatpinyo K, Wipasa J. Vaccine X. 2024 Mar 16;18:100475. doi: 10.1016/j.jvacx.2024.100475. eCollection 2024 Jun. PubMed |
Tumor Cell-Associated IL-1alpha Affects Breast Cancer Progression and Metastasis in Mice through Manipulation of the Tumor Immune Microenvironment. Krishnamohan M, Kaplanov I, Maudi-Boker S, Yousef M, Machluf-Katz N, Cohen I, Elkabets M, Titus J, Bersudsky M, Apte RN, Voronov E, Braiman A. Int J Mol Sci. 2024 Apr 2;25(7):3950. doi: 10.3390/ijms25073950. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.